Search research articles
Contact Us
Filters
Showing results (201-210 of 531) with videos related to
Page
of 54
Sort By:
Antimicrobial Agents and Chemotherapy
|
March 1, 1996
Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections
J K James, S M Palmer, D P Levine, et al.
Human Genetics
|
January 1, 1982
A simple reproducible method for prometaphase chromosome analysis
J Rybak, A Tharapel, S Robinett, et al.
Drug Intelligence & Clinical Pharmacy
|
November 1, 1987
Increased theophylline concentrations secondary to ciprofloxacin
M J Rybak, S K Bowles, P H Chandrasekar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 7, 2002
Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center
Thomas P Lodise, Peggy S McKinnon, Vincent H Tam, et al.
Pharmacotherapy
|
August 6, 1998
Omeprazole-induced exfoliative dermatitis
J A Rebuck, M J Rybak, D P Ramos, et al.
Chest
|
September 16, 2005
Epidemiology, treatment, and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia
C Andrew DeRyke, Thomas P Lodise, Michael J Rybak, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
September 15, 1996
Effect of constructive feedback on pharmacist handling of orders for monitored antimicrobials
F K Zaran, C M Weingarten, M J Rybak, et al.
Antimicrobial Agents and Chemotherapy
|
January 30, 1999
Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus
J R Aeschlimann, L D Dresser, G W Kaatz, et al.
Antimicrobial Agents and Chemotherapy
|
June 1, 1997
Pharmacodynamics of RP 59500 (quinupristin-dalfopristin) administered by intermittent versus continuous infusion against Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model
M J Rybak, H H Houlihan, R C Mercier, et al.
Clinical Pharmacokinetics
|
September 1, 1988
Inhibition of drug metabolism by quinolone antibiotics
D J Edwards, S K Bowles, C K Svensson, et al.
Page
of 54
Search research articles
Search
Showing results (201-210 of 531) with videos related to
Sort By:
Page
of 54
Antimicrobial Agents and Chemotherapy
|
March 1, 1996
Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections
J K James, S M Palmer, D P Levine, et al.
Human Genetics
|
January 1, 1982
A simple reproducible method for prometaphase chromosome analysis
J Rybak, A Tharapel, S Robinett, et al.
Drug Intelligence & Clinical Pharmacy
|
November 1, 1987
Increased theophylline concentrations secondary to ciprofloxacin
M J Rybak, S K Bowles, P H Chandrasekar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 7, 2002
Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center
Thomas P Lodise, Peggy S McKinnon, Vincent H Tam, et al.
Pharmacotherapy
|
August 6, 1998
Omeprazole-induced exfoliative dermatitis
J A Rebuck, M J Rybak, D P Ramos, et al.
Chest
|
September 16, 2005
Epidemiology, treatment, and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia
C Andrew DeRyke, Thomas P Lodise, Michael J Rybak, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
September 15, 1996
Effect of constructive feedback on pharmacist handling of orders for monitored antimicrobials
F K Zaran, C M Weingarten, M J Rybak, et al.
Antimicrobial Agents and Chemotherapy
|
January 30, 1999
Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus
J R Aeschlimann, L D Dresser, G W Kaatz, et al.
Antimicrobial Agents and Chemotherapy
|
June 1, 1997
Pharmacodynamics of RP 59500 (quinupristin-dalfopristin) administered by intermittent versus continuous infusion against Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model
M J Rybak, H H Houlihan, R C Mercier, et al.
Clinical Pharmacokinetics
|
September 1, 1988
Inhibition of drug metabolism by quinolone antibiotics
D J Edwards, S K Bowles, C K Svensson, et al.
Page
of 54